Browsing Tag
clinical trials
131 posts
RTW Biotech Opportunities joins $160.5m Series C of Obsidian Therapeutics
RTW Biotech Opportunities Ltd, an investment company listed on the London Stock Exchange and specialized in the life…
April 7, 2024
Bristol Myers Squibb announces success of KRAZATI in Phase 3 KRYSTAL-12 study
Bristol Myers Squibb (NYSE: BMY) has reached a pivotal milestone in the treatment of non-small cell lung cancer…
April 1, 2024
LENZ Therapeutics announces merger with Graphite Bio to revolutionize presbyopia treatment
In a significant move for the biopharmaceutical industry, LENZ Therapeutics, Inc. (Nasdaq: LENZ), a trailblazer in developing innovative…
March 24, 2024
AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development
In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals…
March 19, 2024
Amylyx Pharmaceuticals’ AMX0035 misses primary and secondary endpoints in ALS study
Cambridge, Massachusetts-based Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a key player in the pharmaceutical industry, announced today the top-line…
March 10, 2024
PCM Trials to enhance decentralized clinical trials with EmVenio Research acquisition
In a significant move to advance decentralized clinical trials (DCTs), Denver-based PCM Trials, the leading independent provider of…
February 26, 2024
Testing laboratories firm Labcorp to spin off clinical development business
Labcorp, an American testing laboratories company, said that its board of directors has authorized it to undertake a…
July 31, 2022
Infosys to acquire Denmark-based BASE life science in €110m deal
Infosys has signed a deal worth up to €110 million to acquire BASE life science, a Denmark-based technology…
July 14, 2022
Pharmacy store giant Walgreens forays into clinical trial business
American pharmacy store chain Walgreens has launched its clinical trial business with the aim of redefining the patient…
June 19, 2022
Lilly begins real-world Covid-19 study of bamlanivimab in New Mexico to assess outcomes in high-risk patients
Eli Lilly begins a real-world Covid-19 study of bamlanivimab in New Mexico. Find out how mobile clinics aim to reduce hospitalizations in high-risk patients.
December 19, 2020